Northwestern Mutual Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Sell
4,655
-113
-2% -$28.2K ﹤0.01% 1324
2025
Q4
$1.15M Buy
4,768
+211
+5% +$54K ﹤0.01% 1246
2025
Q3
$1.25M Sell
4,557
-759
-14% -$207K ﹤0.01% 1163
2025
Q2
$1.37M Buy
5,316
+350
+7% +$83.5K ﹤0.01% 1067
2025
Q1
$1.11M Buy
4,966
+201
+4% +$46.9K ﹤0.01% 1080
2024
Q4
$1.09M Sell
4,765
-162
-3% -$39K ﹤0.01% 1050
2024
Q3
$1.2M Sell
4,927
-206
-4% -$46K ﹤0.01% 999
2024
Q2
$982K Buy
5,133
+1,208
+31% +$245K ﹤0.01% 1030
2024
Q1
$777K Sell
3,925
-648
-14% -$119K ﹤0.01% 1086
2023
Q4
$787K Buy
4,573
+3,089
+208% +$475K ﹤0.01% 1054
2023
Q3
$219K Sell
1,484
-475
-24% -$85.9K ﹤0.01% 1430
2023
Q2
$428K Sell
1,959
-12
-0.6% -$2.67K ﹤0.01% 1202
2023
Q1
$432K Buy
1,971
+519
+36% +$113K ﹤0.01% 1182
2022
Q4
$302K Buy
1,452
+133
+10% +$29.2K ﹤0.01% 1277
2022
Q3
$288K Buy
1,319
+893
+210% +$203K ﹤0.01% 1265
2022
Q2
$90K Buy
426
+75
+21% +$16K ﹤0.01% 1690
2022
Q1
$85K Sell
351
-227
-39% -$54.9K ﹤0.01% 1779
2021
Q4
$150K Buy
578
+501
+651% +$130K ﹤0.01% 1554
2021
Q3
$21K Sell
77
-38
-33% -$10.4K ﹤0.01% 2206
2021
Q2
$29K Buy
115
+35
+44% +$7.36K ﹤0.01% 2048
2021
Q1
$16K Sell
80
-75
-48% -$15K ﹤0.01% 2148
2020
Q4
$33K Sell
155
-13,364
-99% -$2.66M ﹤0.01% 1781
2020
Q3
$2.32M Buy
13,519
+4,067
+43% +$751K 0.01% 403
2020
Q2
$1.81M Buy
9,452
+1,014
+12% +$166K 0.01% 417
2020
Q1
$1.24M Buy
8,438
+4,155
+97% +$662K ﹤0.01% 443
2019
Q4
$664K Buy
4,283
+2,366
+123% +$341K ﹤0.01% 619
2019
Q3
$259K Sell
1,917
-69
-3% -$9.04K ﹤0.01% 810
2019
Q2
$242K Sell
1,986
-207
-9% -$22.9K ﹤0.01% 829
2019
Q1
$228K Sell
2,193
-12
-0.5% -$1.24K ﹤0.01% 831
2018
Q4
$251K Sell
2,205
-235
-10% -$25.2K ﹤0.01% 730
2018
Q3
$281K Sell
2,440
-100
-4% -$11K ﹤0.01% 716
2018
Q2
$263K Sell
2,540
-1,049
-29% -$106K ﹤0.01% 698
2018
Q1
$353K Sell
3,589
-158
-4% -$14.9K ﹤0.01% 591
2017
Q4
$317K Buy
3,747
+189
+5% +$15.6K ﹤0.01% 611
2017
Q3
$274K Buy
3,558
+69
+2% +$5.28K ﹤0.01% 612
2017
Q2
$272K Buy
3,489
+82
+2% +$5.87K ﹤0.01% 609
2017
Q1
$246K Buy
3,407
+1
+0% +$69 ﹤0.01% 601
2016
Q4
$211K Buy
+3,406
New +$209K ﹤0.01% 636
2016
Q3
Sell
-4,002
Closed -$252K 1241
2016
Q2
$252K Buy
4,002
+334
+9% +$19.7K ﹤0.01% 537
2016
Q1
$213K Buy
3,668
+161
+5% +$9.11K ﹤0.01% 555
2015
Q4
$188K Sell
3,507
-333
-9% -$18.8K ﹤0.01% 527
2015
Q3
$196K Buy
3,840
+294
+8% +$15.8K ﹤0.01% 490
2015
Q2
$200K Buy
3,546
+757
+27% +$47.8K 0.01% 459
2015
Q1
$200K Buy
2,789
+138
+5% +$8.96K 0.01% 441
2014
Q4
$149K Sell
2,651
-508
-16% -$26.5K ﹤0.01% 459
2014
Q3
$156K Buy
3,159
+87
+3% +$4.43K 0.01% 445
2014
Q2
$156K Sell
3,072
-3,666
-54% -$182K 0.01% 428
2014
Q1
$301K Buy
6,738
+5,939
+743% +$267K 0.01% 330
2013
Q4
$38K Buy
799
+432
+118% +$21.9K ﹤0.01% 649
2013
Q3
$20K Buy
367
+291
+383% +$14.1K ﹤0.01% 739
2013
Q2
$3K Buy
+76
New +$3.61K ﹤0.01% 1035

Other funds holding RMD

Northwestern Mutual Wealth Management's RMD Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its ResMed (RMD) stake by 2.4% in Q1 2026, selling an estimated $28.2K and leaving 4,655 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Northwestern Mutual Wealth Management first reported a position in RMD in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.32M in Q3 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Northwestern Mutual Wealth Management held 4,655 shares of ResMed worth $1.05M as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 113 ResMed shares in Q1 2026, an estimated $28.2K.
  • ResMed made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #1324 holding.
  • Northwestern Mutual Wealth Management first reported a position in ResMed in Q2 2013 and has held it in 51 quarters since.
  • Northwestern Mutual Wealth Management's ResMed position peaked at $2.32M in Q3 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.